Wells Fargo
TXG icon

Wells Fargo’s 10x Genomics TXG Stock Holding History

Wells Fargo’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,800
Closed -$137K – 7511
2022
Q1 		$137K Buy
+1,800
New +$157K ﹤0.01% 5176

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo's TXG Position: Q2 2026 in Review

Wells Fargo increased its 10x Genomics (TXG) stake by 78% in Q2 2026, buying an estimated $2.87M and bringing the position to 249,644 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Wells Fargo first reported a position in TXG in Q3 2019 and has held it in 28 quarters since. The position peaked at $150M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Wells Fargo held 249,644 shares of 10x Genomics worth $9.57M as of Q2 2026.
  • Wells Fargo bought 109,528 10x Genomics shares in Q2 2026, an estimated $2.87M.
  • 10x Genomics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2223 holding.
  • Wells Fargo first reported a position in 10x Genomics in Q3 2019 and has held it in 28 quarters since.
  • Wells Fargo's 10x Genomics position peaked at $150M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.